{
    "eid": "2-s2.0-85142236252",
    "title": "Real-world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Dermatology",
            "@code": "2708",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "biologics",
        "IL-17",
        "psoriasis",
        "real world",
        "secukinumab"
    ],
    "authors": [
        "Pravit Asawanonda",
        "Bensachee Pattamadilok",
        "Leena Chularojanamontri",
        "Mati Chuamanochan",
        "Charoen Choonhakarn",
        "Panlop Chakkavittumrong",
        "Naruemon Sangob",
        "Natta Rajatanavin"
    ],
    "citedby-count": 0,
    "ref-count": 31,
    "ref-list": [
        "Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study",
        "The factors affecting quality of life in Thai psoriasis patients",
        "Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study",
        "Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany",
        "Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study",
        "A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore",
        "Pathophysiology, clinical presentation, and treatment of psoriasis",
        "A systematic review of worldwide epidemiology of psoriasis",
        "Prevalence and characteristics of psoriasis patients in a primary care area in Thailand",
        "Cognitive process of psoriasis and its comorbidities: from epidemiology to genetics",
        "Update on psoriasis immunopathogenesis and targeted immunotherapy",
        "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics",
        "Secukinumab: first global approval",
        "Old and new biological therapies for psoriasis",
        "Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis",
        "Real-world evidence of secukinumab in psoriasis treatment \u2013 a meta-analysis of 43 studies",
        "Secukinumab in plaque psoriasis \u2013 results of two phase 3 trials",
        "Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial",
        "Real-world satisfaction with secukinumab in clearing the skin of patients with plaque psoriasis through 24 months of follow-up: results from US dermatology electronic medical records",
        "Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation",
        "Effectiveness and safety of secukinumab for psoriasis in a real-world clinical setting in the Asia-Pacific and Middle East regions: results from the REALIA study",
        "Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: real-world evidence in Japan",
        "Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study",
        "Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice",
        "Meta-analysis of the efficacy and safety of secukinumab for the treatment of plaque psoriasis",
        "Regional differences in the prescription of biologics for psoriasis in Sweden: a register-based study of 4168 patients",
        "Healthcare provider type and switch to biologics in psoriasis: evidence from real-world practice",
        "Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis",
        "The risk of infections with biologic therapies for rheumatoid arthritis",
        "Efficacy and safety of secukinumab in elderly subjects with moderate to severe plaque psoriasis: a pooled analysis of phase III studies",
        "Biological therapy in psoriasis: an emphasis on its dermatologic adverse events"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60012521",
            "affilname": "Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012521",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "117742856",
            "affilname": "Novartis",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117742856",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Mahidol University",
        "Leo Pharma"
    ]
}